authors
- Crowther, Mark
- Gold, A
- Lu, G
- Leeds, JM
- Wiens, BL
- Mathur, V
- Castillo, J
- Conley, PB
- Connolly, S
- Curnutte, JT
ANNEXA (TM)-A PART 2: A phase 3 randomized, double-blind, placebo-controlled trial demonstrating sustained reversal of apixaban-induced anticoagulation in older subjects by andexanet ALFA (PRT064445), a universal antidote for factor XA (FXA) inhibitors
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- June 1, 2015
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- Cardiovascular System & Hematology (Science Metrix)